1. Home
  2. TVTX vs BWLP Comparison

TVTX vs BWLP Comparison

Compare TVTX & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • BWLP
  • Stock Information
  • Founded
  • TVTX 2008
  • BWLP 1935
  • Country
  • TVTX United States
  • BWLP Singapore
  • Employees
  • TVTX N/A
  • BWLP N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • BWLP Marine Transportation
  • Sector
  • TVTX Health Care
  • BWLP Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • BWLP Nasdaq
  • Market Cap
  • TVTX 2.5B
  • BWLP 2.4B
  • IPO Year
  • TVTX N/A
  • BWLP N/A
  • Fundamental
  • Price
  • TVTX $29.05
  • BWLP $12.51
  • Analyst Decision
  • TVTX Strong Buy
  • BWLP
  • Analyst Count
  • TVTX 15
  • BWLP 0
  • Target Price
  • TVTX $34.86
  • BWLP N/A
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • BWLP 422.4K
  • Earning Date
  • TVTX 10-30-2025
  • BWLP 11-27-2025
  • Dividend Yield
  • TVTX N/A
  • BWLP 10.80%
  • EPS Growth
  • TVTX N/A
  • BWLP N/A
  • EPS
  • TVTX N/A
  • BWLP 1.50
  • Revenue
  • TVTX $333,865,000.00
  • BWLP $3,554,740,000.00
  • Revenue This Year
  • TVTX $83.23
  • BWLP N/A
  • Revenue Next Year
  • TVTX $41.49
  • BWLP $3.46
  • P/E Ratio
  • TVTX N/A
  • BWLP $8.82
  • Revenue Growth
  • TVTX 87.94
  • BWLP 1.27
  • 52 Week Low
  • TVTX $12.91
  • BWLP $7.86
  • 52 Week High
  • TVTX $28.85
  • BWLP $16.60
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • BWLP 38.92
  • Support Level
  • TVTX $26.79
  • BWLP $12.42
  • Resistance Level
  • TVTX $28.24
  • BWLP $12.87
  • Average True Range (ATR)
  • TVTX 1.02
  • BWLP 0.34
  • MACD
  • TVTX -0.01
  • BWLP 0.04
  • Stochastic Oscillator
  • TVTX 100.00
  • BWLP 44.95

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About BWLP BW LPG Limited Common Shares

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

Share on Social Networks: